These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1838184)

  • 1. Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease.
    Holtzman DM; Li YW; Gage FH; DeArmond SJ; Epstein CJ; McKinley MP; Mobley WC
    Prog Clin Biol Res; 1991; 373():189-202. PubMed ID: 1838184
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms.
    Hol EM; Roelofs RF; Moraal E; Sonnemans MA; Sluijs JA; Proper EA; de Graan PN; Fischer DF; van Leeuwen FW
    Mol Psychiatry; 2003 Sep; 8(9):786-96. PubMed ID: 12931206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome.
    Lane NJ; Balbo A; Rapoport SI
    Cell Biol Int; 1996 Oct; 20(10):673-80. PubMed ID: 8969460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus.
    Harrell LE; Parsons DS; Kolasa K
    Exp Neurol; 2005 Jul; 194(1):182-90. PubMed ID: 15899255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
    Hyde LA; Crnic LS
    Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 13. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse brain histopathology resembles early Alzheimer's disease.
    Higgins LS; Holtzman DM; Rabin J; Mobley WC; Cordell B
    Ann Neurol; 1994 May; 35(5):598-607. PubMed ID: 7513982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.
    Ball MJ; Nuttall K
    Ann Neurol; 1980 May; 7(5):462-5. PubMed ID: 6446875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
    Potter H; Ma J; Das S; Kayyali U
    Prog Clin Biol Res; 1994; 390():57-71. PubMed ID: 7724651
    [No Abstract]   [Full Text] [Related]  

  • 17. Brn-4 is upregulated in the deafferented hippocampus and promotes neuronal differentiation of neural progenitors in vitro.
    Zhang X; Jin G; Wang L; Hu W; Tian M; Qin J; Huang H
    Hippocampus; 2009 Feb; 19(2):176-86. PubMed ID: 18831054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and dementia: new perspectives on an old problem.
    Engel PA
    Conn Med; 1987 Dec; 51(12):785-91. PubMed ID: 2962836
    [No Abstract]   [Full Text] [Related]  

  • 19. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease.
    Mufson EJ; Mash DC; Hersh LB
    Ann Neurol; 1988 Nov; 24(5):623-9. PubMed ID: 3202615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.